Anderson Kim, Rabie Helena, Eley Brian S, Frigati Lisa, Nuttall James, Kalk Emma, Heekes Alexa, Smith Mariette, Boulle Andrew, Mudaly Vanessa, Davies Mary-Ann
Centre for Integrated Data and Epidemiological Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Department of Paediatrics and Child Health, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2025 Apr 15;98(5):506-514. doi: 10.1097/QAI.0000000000003591.
Data on tuberculosis (TB) incidence and risk factors among children living with HIV (CLHIV) in the universal ART era are limited.
We analyzed routinely collected data on TB diagnoses for CLHIV age ≤5 years, born 2018-2022, in the Westen Cape, South Africa. We examined factors associated with TB diagnosis, with death and loss to follow-up as competing events.
Among 2219 CLHIV, 30% were diagnosed with HIV at birth. Median follow-up from birth was 38 months [interquartile range (IQR: 24-50); 90% started antiretroviral therapy (ART). TB was diagnosed in 28% of CLHIV (n = 626/2219); 62% were first diagnosed before/within 3 months of ART start ("TB before ART") and 38% >3 months after ART start ("TB after ART"). Of those with "TB before ART" (n = 390), median age at HIV diagnosis was 13 months (IQR: 6-22); median time between HIV and TB diagnoses was 5 days (IQR: 0-31). "TB before ART" was associated with older age at HIV diagnosis and advanced/severe immunodeficiency. Of those with "TB after ART" (n = 258), median age at HIV diagnosis was 2 months (IQR: 0-8) and median time from ART start to TB diagnosis was 12 months (IQR: 7-21). "TB after ART" was associated with increased viral load and advanced/severe immunosuppression (time updated). Overall, 5% (n = 112/2219) of CLHIV died, 36% of whom were diagnosed with TB (median time from TB diagnosis to death: 58 days; IQR: 17-191).
Young CLHIV in this setting have high TB-associated morbidity and mortality. Efforts to improve early HIV and TB diagnosis, viral suppression, and TB preventive therapy are needed.
在普遍开展抗逆转录病毒治疗(ART)的时代,关于感染人类免疫缺陷病毒(HIV)儿童(CLHIV)的结核病(TB)发病率及危险因素的数据有限。
我们分析了南非西开普省2018年至2022年出生、年龄≤5岁的CLHIV的结核病诊断常规收集数据。我们将与结核病诊断相关的因素作为竞争事件,同时考虑死亡和失访情况进行研究。
在2219名CLHIV中,30%在出生时被诊断出感染HIV。从出生起的中位随访时间为38个月[四分位间距(IQR):24 - 50个月];90%开始接受抗逆转录病毒治疗(ART)。28%的CLHIV(n = 626/2219)被诊断出患有结核病;62%在开始ART之前/3个月内首次被诊断出(“ART前结核病”),38%在开始ART 3个月后被诊断出(“ART后结核病”)。在“ART前结核病”患者(n = 390)中,HIV诊断时的中位年龄为13个月(IQR:6 - 22个月);HIV诊断与结核病诊断之间的中位时间为5天(IQR:0 - 31天)。“ART前结核病”与HIV诊断时年龄较大以及严重免疫缺陷相关。在“ART后结核病”患者(n = 258)中,HIV诊断时的中位年龄为2个月(IQR:0 - 8个月),从开始ART到结核病诊断的中位时间为12个月(IQR:7 - 21个月)。“ART后结核病”与病毒载量增加和严重免疫抑制(时间更新)相关。总体而言,5%(n = 112/2219)的CLHIV死亡,其中36%被诊断出患有结核病(从结核病诊断到死亡的中位时间:58天;IQR:17 - 191天)。
在这种情况下,年轻的CLHIV有较高的结核病相关发病率和死亡率。需要努力改善早期HIV和结核病诊断、病毒抑制以及结核病预防性治疗。